WILMINGTON PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 368 GBX | +4.55% |
|
+3.08% | +10.84% |
| Apr. 26 | Wilmington sells French healthcare business APM for EUR26 million | AN |
| Apr. 26 | Wilmington Sells French Healthcare Unit for EUR26 million | MT |
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company appears highly valued given the size of its balance sheet.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Consumer Publishing
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +10.84% | 392M | C+ | ||
| +2.36% | 8.38B | A | ||
| +9.50% | 6.47B | B | ||
| +38.74% | 5.07B | - | - | |
| +14.98% | 3.56B | D- | ||
| +8.71% | 3.11B | B+ | ||
| +21.44% | 3.08B | C- | ||
| -1.11% | 2.43B | - | ||
| +7.85% | 1.64B | - | ||
| +17.55% | 1.64B | C+ |
Investor Rating
Trading Rating
-
ESG Refinitiv
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- WIL Stock
- Ratings Wilmington plc
